Critical Assessment of Risk Factors for Complications After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei

[1] Sugarbaker PH(1994)Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon Ann Surg 219 109-111

[2] Deraco M(2004)Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 393-398

[3] Baratti D(2001)Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma Eur J Surg Oncol 27 286-290

[4] Inglese M(2007)Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 104-109

[5] Allaria B(2008)Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Br J Surg 95 1164-1171

[6] Andreola S(2004)Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding Br J Surg 91 304-311

[7] Gavazzi C(2007)A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol. 14 484-92

[8] Piso P(2004)Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 3284-3292

[9] Bektas H(2009)Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy Eur J Surg Oncol 35 202-208

[10] Werner U(2004)Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy J Surg Oncol 85 61-67

[1] Sugarbaker PH(1994)Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon Ann Surg 219 109-111

[2] Deraco M(2004)Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 393-398

[3] Baratti D(2001)Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma Eur J Surg Oncol 27 286-290

[4] Inglese M(2007)Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 104-109

[5] Allaria B(2008)Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Br J Surg 95 1164-1171

[6] Andreola S(2004)Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding Br J Surg 91 304-311

[7] Gavazzi C(2007)A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol. 14 484-92

[8] Piso P(2004)Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 3284-3292

[9] Bektas H(2009)Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy Eur J Surg Oncol 35 202-208

[10] Werner U(2004)Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy J Surg Oncol 85 61-67